Funding · Company
Promaxo, Inc.
Oakland, CABiotech & Pharma
Promaxo, Inc. of Oakland, CA has disclosed $42M across 1 Form D offering filed with the SEC on Jul 10, 2024.
$42M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$42M
Form D · Jul 10, 2024 ↗
Q3 2024
· 1 amendment, first filed Apr 8, 2024
· target $57M
Filing details
HeadquartersOakland, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001716053Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →